Literature DB >> 23519918

Estimation of Stratified Mark-Specific Proportional Hazards Models with Missing Marks.

Yanqing Sun1, Peter B Gilbert.   

Abstract

An objective of randomized placebo-controlled preventive HIV vaccine efficacy trials is to assess the relationship between the vaccine effect to prevent infection and the genetic distance of the exposing HIV to the HIV strain represented in the vaccine construct. Motivated by this objective, recently a mark-specific proportional hazards model with a continuum of competing risks has been studied, where the genetic distance of the transmitting strain is the continuous `mark' defined and observable only in failures. A high percentage of genetic marks of interest may be missing for a variety of reasons, predominantly due to rapid evolution of HIV sequences after transmission before a blood sample is drawn from which HIV sequences are measured. This research investigates the stratified mark-specific proportional hazards model with missing marks where the baseline functions may vary with strata. We develop two consistent estimation approaches, the first based on the inverse probability weighted complete-case (IPW) technique, and the second based on augmenting the IPW estimator by incorporating auxiliary information predictive of the mark. We investigate the asymptotic properties and finite-sample performance of the two estimators, and show that the augmented IPW estimator, which satisfies a double robustness property, is more efficient.

Entities:  

Keywords:  Augmented inverse probability weighted complete-case estimator; HIV vaccine trial; auxiliary marks; competing risks; double robustness; failure time data; genetic data; mark-specific vaccine efficacy; missing at random; semiparametric model

Year:  2012        PMID: 23519918      PMCID: PMC3601495          DOI: 10.1111/j.1467-9469.2011.00746.x

Source DB:  PubMed          Journal:  Scand Stat Theory Appl        ISSN: 0303-6898            Impact factor:   1.396


  9 in total

1.  Statistical measures of DNA sequence dissimilarity under Markov chain models of base composition.

Authors:  T J Wu; Y C Hsieh; L A Li
Journal:  Biometrics       Date:  2001-06       Impact factor: 2.571

2.  Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure.

Authors:  K Lu; A A Tsiatis
Journal:  Biometrics       Date:  2001-12       Impact factor: 2.571

3.  Tests for comparing mark-specific hazards and cumulative incidence functions.

Authors:  Peter B Gilbert; Ian W McKeague; Yanqing Sun
Journal:  Lifetime Data Anal       Date:  2004-03       Impact factor: 1.588

4.  The 2-sample problem for failure rates depending on a continuous mark: an application to vaccine efficacy.

Authors:  Peter B Gilbert; Ian W McKeague; Yanqing Sun
Journal:  Biostatistics       Date:  2007-08-17       Impact factor: 5.899

5.  HIV vaccine research: the way forward.

Authors:  Anthony S Fauci; Margaret I Johnston; Carl W Dieffenbach; Dennis R Burton; Scott M Hammer; James A Hoxie; Malcolm Martin; Julie Overbaugh; David I Watkins; Adel Mahmoud; Warner C Greene
Journal:  Science       Date:  2008-07-25       Impact factor: 47.728

6.  Nonparametric estimation of the survival function when cause of death is uncertain.

Authors:  A H Racine-Poon; D G Hoel
Journal:  Biometrics       Date:  1984-12       Impact factor: 2.571

7.  Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.

Authors:  Neil M Flynn; Donald N Forthal; Clayton D Harro; Franklyn N Judson; Kenneth H Mayer; Michael F Para
Journal:  J Infect Dis       Date:  2005-01-27       Impact factor: 5.226

8.  PROPORTIONAL HAZARDS MODELS WITH CONTINUOUS MARKS.

Authors:  Yanqing Sun; Peter B Gilbert; Ian W McKeague
Journal:  Ann Stat       Date:  2009-02-01       Impact factor: 4.028

9.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection.

Authors:  Brandon F Keele; Elena E Giorgi; Jesus F Salazar-Gonzalez; Julie M Decker; Kimmy T Pham; Maria G Salazar; Chuanxi Sun; Truman Grayson; Shuyi Wang; Hui Li; Xiping Wei; Chunlai Jiang; Jennifer L Kirchherr; Feng Gao; Jeffery A Anderson; Li-Hua Ping; Ronald Swanstrom; Georgia D Tomaras; William A Blattner; Paul A Goepfert; J Michael Kilby; Michael S Saag; Eric L Delwart; Michael P Busch; Myron S Cohen; David C Montefiori; Barton F Haynes; Brian Gaschen; Gayathri S Athreya; Ha Y Lee; Natasha Wood; Cathal Seoighe; Alan S Perelson; Tanmoy Bhattacharya; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-19       Impact factor: 11.205

  9 in total
  14 in total

1.  Mark-specific hazard ratio model with missing multivariate marks.

Authors:  Michal Juraska; Peter B Gilbert
Journal:  Lifetime Data Anal       Date:  2015-10-28       Impact factor: 1.588

2.  Analysis of HLA A*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.

Authors:  Andrew J Gartland; Sue Li; John McNevin; Georgia D Tomaras; Raphael Gottardo; Holly Janes; Youyi Fong; Daryl Morris; Daniel E Geraghty; Gustavo H Kijak; Paul T Edlefsen; Nicole Frahm; Brendan B Larsen; Sodsai Tovanabutra; Eric Sanders-Buell; Allan C deCamp; Craig A Magaret; Hasan Ahmed; Jodie P Goodridge; Lennie Chen; Philip Konopa; Snehal Nariya; Julia N Stoddard; Kim Wong; Hong Zhao; Wenjie Deng; Brandon S Maust; Meera Bose; Shana Howell; Adam Bates; Michelle Lazzaro; Annemarie O'Sullivan; Esther Lei; Andrea Bradfield; Grace Ibitamuno; Vatcharain Assawadarachai; Robert J O'Connell; Mark S deSouza; Sorachai Nitayaphan; Supachai Rerks-Ngarm; Merlin L Robb; John Sidney; Alessandro Sette; Susan Zolla-Pazner; David Montefiori; M Juliana McElrath; James I Mullins; Jerome H Kim; Peter B Gilbert; Tomer Hertz
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

3.  Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causes.

Authors:  Fei Heng; Yanqing Sun; Seunggeun Hyun; Peter B Gilbert
Journal:  Lifetime Data Anal       Date:  2020-04-09       Impact factor: 1.588

4.  Goodness-of-fit test of the stratified mark-specific proportional hazards model with continuous mark.

Authors:  Yanqing Sun; Mei Li; Peter B Gilbert
Journal:  Comput Stat Data Anal       Date:  2014-12-03       Impact factor: 1.681

5.  Estimation of Stratified Mark-Specific Proportional Hazards Models under Two-Phase Sampling with Application to HIV Vaccine Efficacy Trials.

Authors:  Guangren Yang; Yanqing Sun; Li Qi; Peter B Gilbert
Journal:  Stat Biosci       Date:  2016-10-27

6.  Mark-specific additive hazards regression with continuous marks.

Authors:  Dongxiao Han; Liuquan Sun; Yanqing Sun; Li Qi
Journal:  Lifetime Data Anal       Date:  2016-05-11       Impact factor: 1.588

7.  Mark-specific proportional hazards model with multivariate continuous marks and its application to HIV vaccine efficacy trials.

Authors:  Yanqing Sun; Mei Li; Peter B Gilbert
Journal:  Biostatistics       Date:  2012-07-03       Impact factor: 5.899

8.  Inferences on relative failure rates in stratified mark-specific proportional hazards models with missing marks, with application to HIV vaccine efficacy trials.

Authors:  Peter B Gilbert; Yanqing Sun
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2015-01-01       Impact factor: 1.864

9.  A Hybrid Approach for the Stratified Mark-Specific Proportional Hazards Model with Missing Covariates and Missing Marks, with Application to Vaccine Efficacy Trials.

Authors:  Yanqing Sun; Li Qi; Fei Heng; Peter B Gilbert
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2020-05-22       Impact factor: 1.864

10.  Analysis of two-phase sampling data with semiparametric additive hazards models.

Authors:  Yanqing Sun; Xiyuan Qian; Qiong Shou; Peter B Gilbert
Journal:  Lifetime Data Anal       Date:  2016-03-19       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.